Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.53 HKD
Change Today +0.02 / 3.92%
Volume 13.0M
As of 3:09 AM 05/7/15 All times are local (Market data is delayed by at least 15 minutes).

rui kang pharmaceutical grou (8037) Snapshot

Open
$0.51
Previous Close
$0.51
Day High
$0.56
Day Low
$0.51
52 Week High
05/28/14 - $1.43
52 Week Low
04/15/15 - $0.31
Market Cap
133.9M
Average Volume 10 Days
13.2M
EPS TTM
$-0.80
Shares Outstanding
252.7M
EX-Date
08/15/05
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RUI KANG PHARMACEUTICAL GROU (8037)

Related News

No related news articles were found.

rui kang pharmaceutical grou (8037) Related Businessweek News

No Related Businessweek News Found

rui kang pharmaceutical grou (8037) Details

Rui Kang Pharmaceutical Group Investments Limited, an investment holding company, is engaged in the research and development, manufacture, distribution, and sale of consumer cosmetics, health related and pharmaceutical products, health supplement wine, and dental materials and equipment in the People’s Republic of China and Hong Kong. It also trades in securities in Hong Kong; and manufactures and sells household commodities, as well as trades in household commodities and health related products. The company was formerly known as Longlife Group Holdings Limited and changed its name to Rui Kang Pharmaceutical Group Investments Limited in May 2014. Rui Kang Pharmaceutical Group Investments Limited was founded in 1996 and is based in Kowloon, Hong Kong.

417 Employees
Last Reported Date: 03/23/15
Founded in 1996

rui kang pharmaceutical grou (8037) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: $262.0K
Chairman, Chairman of Nomination Committee an...
Total Annual Compensation: $3.7M
Compliance Officer, Executive Director and Me...
Total Annual Compensation: $673.0K
Compensation as of Fiscal Year 2013.

rui kang pharmaceutical grou (8037) Key Developments

Rui Kang Pharmaceutical Group Investments Limited Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Rui Kang Pharmaceutical Group Investments Limited reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported turnover of HKD 140,385,000 against HKD 106,625,000 a year ago. Loss from operations was HKD 63,430,000 against HKD 42,837,000 a year ago. Loss before tax was HKD 82,333,000 against HKD 74,630,000 a year ago. Loss from continuing operations was HKD 82,946,000 against HKD 75,289,000 a year ago. Loss attributable to owners of the company was HKD 82,929,000 against HKD 47,281,000 a year ago. Loss per share continuing operations basic and diluted was HKD 0.123 against HKD 0.266 a year ago. Net cash used in operating activities was HKD 40,011,000 against HKD 52,150,000 a year ago. Purchases of property, plant and equipment was HKD 2,763,000 against HKD 4,614,000 a year ago.

Rui Kang Pharmaceutical Group Investments Limited, Special/Extraordinary Shareholders Meeting, Mar 31, 2015

Rui Kang Pharmaceutical Group Investments Limited, Special/Extraordinary Shareholders Meeting, Mar 31, 2015., at 11:00 China Standard Time. Location: Narcissus Room, the Garden Rooms, 2/F, the Royal Garden Hotel. Agenda: To approve the share consolidation of every five issued and unissued ordinary shares of HKD 0.01 each in the share capital of the company into one consolidated share of HKD 0.05 in the issued and unissued share capital of the Company and to authorize the directors of the company to do all such acts as they consider necessary to give effect to the share consolidation.

Rui Kang Pharmaceutical Group Investments Limited to Report Fiscal Year 2014 Results on Mar 17, 2015

Rui Kang Pharmaceutical Group Investments Limited announced that they will report fiscal year 2014 results on Mar 17, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8037:HK $0.53 HKD +0.02

8037 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8037.
View Industry Companies
 

Industry Analysis

8037

Industry Average

Valuation 8037 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RUI KANG PHARMACEUTICAL GROU, please visit www.ruikang.com.hk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.